Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. med. biol. res ; 46(3): 278-286, 15/mar. 2013. tab, graf
Article Dans Anglais | LILACS | ID: lil-670894

Résumé

The antioxidant and free radical scavenger properties of melatonin have been well described in the literature. In this study, our objective was to determine the protective effect of the pineal gland hormone against the DNA damage induced by cyclophosphamide (CP), an anti-tumor agent that is widely applied in clinical practice. DNA damage was induced in rats by a single intraperitoneal injection of CP (20 or 50 mg/kg). Animals received melatonin during the dark period for 15 days (1 mg/kg in the drinking water). Rat bone marrow cells were used for the determination of chromosomal aberrations and of formamidopyrimidine DNA glycosylase enzyme (Fpg)-sensitive sites by the comet technique and of Xpf mRNA expression by qRT-PCR. The number (mean ± SE) of chromosomal aberrations in pinealectomized (PINX) animals treated with melatonin and CP (2.50 ± 0.50/100 cells) was lower than that obtained for PINX animals injected with CP (12 ± 1.8/100 cells), thus showing a reduction of 85.8% in the number of chromosomal aberrations. This melatonin-mediated protection was also observed when oxidative lesions were analyzed by the Fpg-sensitive assay, both 24 and 48 h after CP administration. The expression of Xpf mRNA, which is involved in the DNA nucleotide excision repair machinery, was up-regulated by melatonin. The results indicate that melatonin is able to protect bone marrow cells by completely blocking CP-induced chromosome aberrations. Therefore, melatonin administration could be an alternative and effective treatment during chemotherapy.


Sujets)
Animaux , Mâle , Antioxydants/administration et posologie , Altération de l'ADN/effets des médicaments et des substances chimiques , Mélatonine/administration et posologie , Aberrations des chromosomes , Cyclophosphamide , Injections péritoneales , Mutagènes , Oxydoréduction , Rat Wistar
2.
Braz. j. med. biol. res ; 44(7): 694-699, July 2011. ilus, tab
Article Dans Anglais | LILACS | ID: lil-595703

Résumé

The maxilla and masseter muscles are components of the stomatognathic system involved in chewing, which is frequently affected by physical forces such as gravity, and by dental, orthodontic and orthopedic procedures. Thyroid hormones (TH) are known to regulate the expression of genes that control bone mass and the oxidative properties of muscles; however, little is known about the effects of TH on the stomatognathic system. This study investigated this issue by evaluating: i) osteoprotegerin (OPG) and osteopontine (OPN) mRNA expression in the maxilla and ii) myoglobin (Mb) mRNA and protein expression, as well as fiber composition of the masseter. Male Wistar rats (~250 g) were divided into thyroidectomized (Tx) and sham-operated (SO) groups (N = 24/group) treated with T3 or saline (0.9 percent) for 15 days. Thyroidectomy increased OPG (~40 percent) and OPN (~75 percent) mRNA expression, while T3 treatment reduced OPG (~40 percent) and OPN (~75 percent) in Tx, and both (~50 percent) in SO rats. Masseter Mb mRNA expression and fiber type composition remained unchanged, despite the induction of hypo- and hyperthyroidism. However, Mb content was decreased in Tx rats even after T3 treatment. Since OPG and OPN are key proteins involved in the osteoclastogenesis inhibition and bone mineralization, respectively, and that Mb functions as a muscle store of O2 allowing muscles to be more resistant to fatigue, the present data indicate that TH also interfere with maxilla remodeling and the oxidative properties of the masseter, influencing the function of the stomatognathic system, which may require attention during dental, orthodontic and orthopedic procedures in patients with thyroid diseases.


Sujets)
Animaux , Mâle , Rats , Muscle masséter/effets des médicaments et des substances chimiques , Maxillaire/effets des médicaments et des substances chimiques , Myoglobine/métabolisme , Ostéopontine/métabolisme , Ostéoprotégérine/métabolisme , Hormones thyroïdiennes/physiologie , Tri-iodothyronine/pharmacologie , Technique de Northern , Hyperthyroïdie/physiopathologie , Muscle masséter/anatomie et histologie , Muscle masséter/métabolisme , Maxillaire/métabolisme , Myoglobine/génétique , Ostéopontine/génétique , Ostéoprotégérine/génétique , Rat Wistar , RT-PCR , ARN , ARN messager/métabolisme , Thyroïdectomie , Hormones thyroïdiennes/métabolisme
SÉLECTION CITATIONS
Détails de la recherche